-+ 0.00%
-+ 0.00%
-+ 0.00%

PROPANC BIOPHARMA - TO START OPEN-LABEL PHASE 1B STUDY OF PRP IN Q1 2027 ENROLLING UP TO 50 PATIENTS

Reuters·10/07/2026 12:35:07